News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
CEO de Peaches anunciando aprobación ensayo tormenta citoquinas
AEMPS approves Peaches clinical trial with selective secretomes to treat COVID-19-associated cytokine storm
Healthcare · Innovative drugs · Personalized medicine
Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will help combat…
Partners - PEACHES BIOTECH S.L.
forma pivotal
Fundación Teófilo Hernando, CRO in Spain of a pivotal clinical study with the first medical device designed to restore natural breast shape and sensitivity after partial mastectomy
Healthcare · Access to innovation · Personalized medicine
The international study involves the Complexo Hospitalario Universitario de A Coruña in Spain and…
Partners - Fundación Teófilo Hernando (FTH)
hojas de olivo cener
CENER pioneers breakthrough biotechnological solutions for olive leaf valorization
Industrial biotechnology · Bioeconomy
The OLEAF4VALUE project is an ambitious initiative funded by the European Union under the Horizon…
Partners - CENER
Therapies manufacturing - alira health
Alira Health Releases 2024 Biologics and Advanced Therapies CDMO Market Report Amid Continued Macro-Economic Uncertainty
Healthcare · Drug discovery · Advanced therapies · International
Despite market contraction in 2023, strategic interest in biologics and advanced therapies remains…
Equipo Asabys
Asabys Announces the Closing of €180M Oversubscribed Sabadell Asabys II Fund
Healthcare · Financing · Digitalization
Similar to Sabadell Asabys Fund I, the Fund II portfolio will include companies within the fields…
Partners - Asabys Partners
Trastorno límite de la personalidad
ORYZON receives minutes from End-of-Phase II meeting with the FDA on the PORTICO-2 Phase III vafidemstat trial in Borderline Personality Disorder
Healthcare · Innovative drugs
Oryzon may use STAXI-2 Trait anger as a primary efficacy endpoint for PORTICO-2.
Partners - Oryzon Genomics
Pedro Martínez Córdoba, Concejal de Promoción Económica del Ayuntamiento de Salamanca
“The Green Innovation Forum will help us learn from other successful projects and models, broaden our perspectives, and exchange experiences”
Climate change · Bioeconomy · Circular economy
We interviewed Pedro Martínez Córdoba, Councilman for Economic Promotion at the Salamanca City…
AseBio - AYUNTAMIENTO DE SALAMANCA
simbionte
Simbionte joins Lanzadera to become the go-to solution for Biotech SMEs looking to boost their online presence and generate leads
International · EU projects · Financing · Talento
Simbionte has been selected to join Lanzadera, one of the leading acceleration programs in Europe.…
Partners - SIMBIONTE
investigación
Cash Need and Valuation: two key elements for a successful Investment Round
Financing
 Before carrying out any investment round, it is essential to first quantify the start-up/spin…
Partners - GENESIS Biomed